Stocktoria

DarioHealth Corp. DRIO

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-03-08

DarioHealth Corp. statistics & valuation

Market cap$51.4M
P / S2.3×
P / B0.8×
Net margin-186.6%
Return on equity-61.4%
FCF margin-116.7%
Net debt$8.9M
Enterprise value USD$60.4M
Earnings yield EBIT/EV-60.7%
Return on capital-36.4%
Graham number +532.7%$47.32

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($47.32); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-388.40% -304.50% -240.80% -234.60% -388.70% -374.20% -224.90% -292.00% -158.10% -186.60% 2016201720182019202020212022202320242025
Gross margin (%)
-29.60% 25.40% 23.90% 34.40% 33.20% 19.30% 34.90% 29.40% 49.10% 56.60% 2016201720182019202020212022202320242025
Operating margin (%)
-396.00% -278.90% -239.20% -234.20% -394.70% -372.90% -205.40% -276.10% -213.60% -163.90% 2016201720182019202020212022202320242025
Return on equity (%)
-399.50% -199.50% -93.90% -104.60% -89.70% -77.70% -102.20% -59.40% -61.40% 2016201720182019202020212022202320242025
Shares outstanding
5.7M 14.1M 1.8M 2.2M 8.1M 16.6M 25.7M 28.4M 2.5M 6.9M 2016201720182019202020212022202320242025
Net debt ($)
-$35.8M -$31.3M -$12.2M -$4.3M $8.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-281.20% -226.30% -126.40% -72.20% -83.20% -76.20% -52.20% -61.70% -36.00% -37.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-327.80% -209.20% -156.10% -209.30% -235.70% -247.00% -174.60% -152.10% -143.10% -116.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.23× 0.42× 0.33× 0.45× 2016201720182019202020212022202320242025
EPS ($)
$4.01 $4.07 $2.54 $1.93 $12.27 $10.12 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

DarioHealth Corp. trades at about 0.7× earnings — below its 10-year norm (10-year range 1×–108×, median 43.1×).

0.7× 108×

Shaded band = 10-year range (1×–108×); dot = today's 0.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin56.6%49.1%29.4%34.9%19.3%33.2%34.4%23.9%25.4%-29.6%
Operating margin-163.9%-213.6%-276.1%-205.4%-372.9%-394.7%-234.2%-239.2%-278.9%-396.0%
Net margin-186.6%-158.1%-292.0%-224.9%-374.2%-388.7%-234.6%-240.8%-304.5%-388.4%
FCF margin-116.7%-143.1%-152.1%-174.6%-247.0%-235.7%-209.3%-156.1%-209.2%-327.8%
Return on assets-37.9%-36.0%-61.7%-52.2%-76.2%-83.2%-72.2%-126.4%-226.3%-281.2%
Return on equity-61.4%-59.4%-102.2%-77.7%-89.7%-104.6%-93.9%-199.5%-399.5%166.4%
Debt / equity0.45×0.33×0.42×0.23×0.00×—————
Current ratio3.762.443.793.393.174.854.392.542.011.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.